Episode

Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD

Podcast: Neurology Minute
Published: Jun 25, 2026
Duration seconds: 97
Processing state: not_requested
Canonical source: https://neurologyminute.libsyn.com/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad
Audio: https://traffic.libsyn.com/secure/neurologyminute/04_June_25th_2026_nm_v2.mp3?dest-id=1085030
JSON: /v1/public/podcasts/neurology-minute-15117/episodes/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad
Markdown: /podcast/neurology-minute-15117/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad.md

Actions

POST https://stenobird.com/v1/public/podcasts/neurology-minute-15117/episodes/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/neurology-minute-15117/safety-and-efficacy-of-satralizumab-in-patients-with-relapsing-mogad.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Dr. Shuvro Roy and Dr. Michael Levy discuss satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. Read more about this abstract .